172 related articles for article (PubMed ID: 19545421)
1. KIF11 inhibition for glioblastoma treatment: reason to hope or a struggle with the brain?
Valensin S; Ghiron C; Lamanna C; Kremer A; Rossi M; Ferruzzi P; Nievo M; Bakker A
BMC Cancer; 2009 Jun; 9():196. PubMed ID: 19545421
[TBL] [Abstract][Full Text] [Related]
2. Enhancing Brain Retention of a KIF11 Inhibitor Significantly Improves its Efficacy in a Mouse Model of Glioblastoma.
Gampa G; Kenchappa RS; Mohammad AS; Parrish KE; Kim M; Crish JF; Luu A; West R; Hinojosa AQ; Sarkaria JN; Rosenfeld SS; Elmquist WF
Sci Rep; 2020 Apr; 10(1):6524. PubMed ID: 32300151
[TBL] [Abstract][Full Text] [Related]
3. KIF11 inhibitors filanesib and ispinesib inhibit meningioma growth in vitro and in vivo.
Jungwirth G; Yu T; Cao J; Eddine MA; Moustafa M; Warta R; Debus J; Unterberg A; Abdollahi A; Herold-Mende C
Cancer Lett; 2021 May; 506():1-10. PubMed ID: 33652084
[TBL] [Abstract][Full Text] [Related]
4. Targeting the Id1-Kif11 Axis in Triple-Negative Breast Cancer Using Combination Therapy.
Thankamony AP; Murali R; Karthikeyan N; Varghese BA; Teo WS; McFarland A; Roden DL; Holliday H; Konrad CV; Cazet A; Dodson E; Yang J; Baker LA; George JT; Levine H; Jolly MK; Swarbrick A; Nair R
Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32911668
[TBL] [Abstract][Full Text] [Related]
5. Initial testing (stage 1) of the kinesin spindle protein inhibitor ispinesib by the pediatric preclinical testing program.
Carol H; Lock R; Houghton PJ; Morton CL; Kolb EA; Gorlick R; Reynolds CP; Maris JM; Keir ST; Billups CA; Smith MA
Pediatr Blood Cancer; 2009 Dec; 53(7):1255-63. PubMed ID: 19554570
[TBL] [Abstract][Full Text] [Related]
6. Inhibitors of kinesin Eg5: antiproliferative activity of monastrol analogues against human glioblastoma cells.
Müller C; Gross D; Sarli V; Gartner M; Giannis A; Bernhardt G; Buschauer A
Cancer Chemother Pharmacol; 2007 Feb; 59(2):157-64. PubMed ID: 16703323
[TBL] [Abstract][Full Text] [Related]
7. Multiplexed single-cell lineage tracing of mitotic kinesin inhibitor resistance in glioblastoma.
Cheng YL; Banu MA; Zhao W; Rosenfeld SS; Canoll P; Sims PA
Cell Rep; 2024 May; 43(5):114139. PubMed ID: 38652658
[TBL] [Abstract][Full Text] [Related]
8. Improving Localized Radiotherapy for Glioblastoma via Small Molecule Inhibition of KIF11.
Tallman MM; Zalenski AA; Stabl I; Schrock MS; Kollin L; de Jong E; De K; Grubb TM; Summers MK; Venere M
Cancers (Basel); 2023 Jun; 15(12):. PubMed ID: 37370783
[TBL] [Abstract][Full Text] [Related]
9. Activity of the kinesin spindle protein inhibitor ispinesib (SB-715992) in models of breast cancer.
Purcell JW; Davis J; Reddy M; Martin S; Samayoa K; Vo H; Thomsen K; Bean P; Kuo WL; Ziyad S; Billig J; Feiler HS; Gray JW; Wood KW; Cases S
Clin Cancer Res; 2010 Jan; 16(2):566-76. PubMed ID: 20068098
[TBL] [Abstract][Full Text] [Related]
10. Inhibitor library screening identifies ispinesib as a new potential chemotherapeutic agent for pancreatic cancers.
Murase Y; Ono H; Ogawa K; Yoshioka R; Ishikawa Y; Ueda H; Akahoshi K; Ban D; Kudo A; Tanaka S; Tanabe M
Cancer Sci; 2021 Nov; 112(11):4641-4654. PubMed ID: 34510663
[TBL] [Abstract][Full Text] [Related]
11. Combined Inhibition of KIF11 and KIF15 as an Effective Therapeutic Strategy for Gastric Cancer.
Sun RF; He N; Zhang GY; Yu ZY; Li LS; Ma ZJ; Jiao ZY
Curr Cancer Drug Targets; 2023; 23(4):293-306. PubMed ID: 35713129
[TBL] [Abstract][Full Text] [Related]
12. Multiplexed single-cell lineage tracing of mitotic kinesin inhibitor resistance in glioblastoma.
Cheng YL; Banu MA; Zhao W; Rosenfeld SS; Canoll P; Sims PA
bioRxiv; 2023 Sep; ():. PubMed ID: 37745469
[TBL] [Abstract][Full Text] [Related]
13. Expression and pharmacological inhibition of TrkB and EGFR in glioblastoma.
Pinheiro KV; Thomaz A; Souza BK; Metcalfe VA; Freire NH; Brunetto AT; de Farias CB; Jaeger M; Bambini V; Smith CGS; Shaw L; Roesler R
Mol Biol Rep; 2020 Sep; 47(9):6817-6828. PubMed ID: 32862352
[TBL] [Abstract][Full Text] [Related]
14. The mitotic kinesin KIF11 is a driver of invasion, proliferation, and self-renewal in glioblastoma.
Venere M; Horbinski C; Crish JF; Jin X; Vasanji A; Major J; Burrows AC; Chang C; Prokop J; Wu Q; Sims PA; Canoll P; Summers MK; Rosenfeld SS; Rich JN
Sci Transl Med; 2015 Sep; 7(304):304ra143. PubMed ID: 26355032
[TBL] [Abstract][Full Text] [Related]
15. Mitotic slippage and expression of survivin are linked to differential sensitivity of human cancer cell-lines to the Kinesin-5 inhibitor monastrol.
Asraf H; Avunie-Masala R; Hershfinkel M; Gheber L
PLoS One; 2015; 10(6):e0129255. PubMed ID: 26035434
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of inhibition of human KSP by ispinesib.
Lad L; Luo L; Carson JD; Wood KW; Hartman JJ; Copeland RA; Sakowicz R
Biochemistry; 2008 Mar; 47(11):3576-85. PubMed ID: 18290633
[TBL] [Abstract][Full Text] [Related]
17. Progress on kinesin spindle protein inhibitors as anti-cancer agents.
Zhang Y; Xu W
Anticancer Agents Med Chem; 2008 Aug; 8(6):698-704. PubMed ID: 18690830
[TBL] [Abstract][Full Text] [Related]
18. Probing spindle assembly mechanisms with monastrol, a small molecule inhibitor of the mitotic kinesin, Eg5.
Kapoor TM; Mayer TU; Coughlin ML; Mitchison TJ
J Cell Biol; 2000 Sep; 150(5):975-88. PubMed ID: 10973989
[TBL] [Abstract][Full Text] [Related]
19. Metal-Dependent Cytotoxic and Kinesin Spindle Protein Inhibitory Activity of Ru, Os, Rh, and Ir Half-Sandwich Complexes of Ispinesib-Derived Ligands.
Łomzik M; Hanif M; Budniok A; Błauż A; Makal A; Tchoń DM; Leśniewska B; Tong KKH; Movassaghi S; Söhnel T; Jamieson SMF; Zafar A; Reynisson J; Rychlik B; Hartinger CG; Plażuk D
Inorg Chem; 2020 Oct; 59(20):14879-14890. PubMed ID: 33003697
[TBL] [Abstract][Full Text] [Related]
20. Functional genetic screens identify genes essential for tumor cell survival in head and neck and lung cancer.
Martens-de Kemp SR; Nagel R; Stigter-van Walsum M; van der Meulen IH; van Beusechem VW; Braakhuis BJ; Brakenhoff RH
Clin Cancer Res; 2013 Apr; 19(8):1994-2003. PubMed ID: 23444224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
